Taiwania Capital Management Corporation

Surglasses is a Taiwanese medical technology company specializing in the development and distribution of innovative surgical navigation and educational solutions. The company's patented technology is used in high-performance surgical systems and educational products, offering a cost-effective alternative to traditional surgical planning tools. Surglasses' products, including the CE-approved Foresee-X smart surgical glasses with Augmented Reality, and the Caduceus for spine surgical navigation with 3D Mixed Reality, aim to enhance surgery safety, precision, and efficiency. The company, certified with CE Mark, ISO-13485, and GMP, is committed to continuous R&D to meet the needs of surgeons, physicians, and patients, and to contribute to advancements in medical electronics and minimally invasive surgery.

PharmaEssentia is a biopharmaceutical company specializing in the research, development, production, and sale of therapeutic products for treating human diseases. Its primary focus areas include hematology, oncology, and infectious diseases. The company's flagship product is ropeginterferon alfa-2b, used to treat conditions such as polycythemia vera and hepatitis B/C.

EirGenix is a Taiwan-based contract development and manufacturing organization that specializes in biologics. It offers cell line development and cell bank manufacturing, process development, analytical sciences and quality control, and cGMP manufacturing, including antibody-drug conjugate production. The company operates two business units: contract development and manufacturing operation and product development operation, applying its team’s experience to biosimilars, biobetters, and new biologics. It runs two PIC/S GMP facilities for mammalian and microbial production to support clinical trial and commercial manufacturing. Founded in 2012 and headquartered in New Taipei City, EirGenix also develops and provides biopharmaceutical products such as CRM197 carrier protein and a COVID-19 antigen rapid test.

SyneuRx International Taiwan is a biomedical company focused on the development of innovative treatments for central nervous system disorders, particularly targeting schizophrenia, depression, and dementia. The company is advancing its clinical pipeline with several drug candidates, including SND-11, SND-12, and SND-13, the latter of which is currently undergoing Phase IIb/III clinical trials as an add-on therapy for schizophrenia. By concentrating on these critical mental health issues, SyneuRx aims to provide effective therapeutic options for patients suffering from these debilitating conditions.

TFBS Bioscience Inc is a Contract Research Organization (CRO) based in Taiwan that specializes in biological testing and offers comprehensive services for the biopharmaceutical industry. The company provides critical support for cell and gene therapy products, which includes viral vector manufacturing, biosafety testing, and product release testing. Additionally, TFBS Bioscience conducts cell bank characterization, viral clearance, bulk and lot release testing, assay development—both in vitro and in vivo— and clinical sample analysis. The organization is also involved in cleaning validation for reusable medical devices, ensuring compliance with safety standards. Through its diverse range of services, TFBS Bioscience plays a pivotal role in advancing the development and commercialization of innovative medical therapies.

Tripresso is an online travel agency based in Taipei, Taiwan, founded in 2013. The company specializes in package tour products, initially providing a marketplace for suppliers and a simple search engine for customers seeking suitable travel options. Over time, Tripresso expanded its offerings to include hotels, flight tickets, and customized travel plans for outbound travel. In 2018, it introduced TripSaaS, a proprietary software-as-a-service platform designed for brick-and-mortar travel agencies. This system facilitates the management of websites, product listings, orders, and customer relationships, ultimately enhancing operational efficiency. By leveraging data and partnerships with both online and offline travel information sources, Tripresso creates efficient travel planning networks that help users discover affordable travel packages.

Dcard is a social networking platform based in Taipei, Taiwan, that was founded in 2015. It serves as Taiwan's largest anonymous communication platform, designed specifically for students. Dcard facilitates the sharing of ideas and experiences among users, fostering a sense of community within the campus environment. By allowing individuals to connect without the constraints of background, age, or interest, Dcard creates a comfortable and trustworthy space for students to engage and interact. The platform emphasizes anonymity, enabling users to share their thoughts and experiences freely.

EirGenix is a Taiwan-based contract development and manufacturing organization that specializes in biologics. It offers cell line development and cell bank manufacturing, process development, analytical sciences and quality control, and cGMP manufacturing, including antibody-drug conjugate production. The company operates two business units: contract development and manufacturing operation and product development operation, applying its team’s experience to biosimilars, biobetters, and new biologics. It runs two PIC/S GMP facilities for mammalian and microbial production to support clinical trial and commercial manufacturing. Founded in 2012 and headquartered in New Taipei City, EirGenix also develops and provides biopharmaceutical products such as CRM197 carrier protein and a COVID-19 antigen rapid test.

Metanoia Communications Inc., founded in 2004 and based in Hsinchu City, Taiwan, specializes in the development of semiconductor and software solutions for the wireline broadband and in-home networking markets. The company manufactures high-speed PHY chipsets, including products for VDSL2, G.fast, and G.hn technologies, targeting broadband manufacturers. Metanoia leverages advanced system architecture and algorithm expertise alongside its integrated circuit design capabilities to deliver a comprehensive range of fixed-line communication products suitable for access and in-home applications. As a subsidiary of ELAN Microelectronics Corporation, Metanoia is positioned to meet the growing demands of high-speed internet connectivity.

Tripresso is an online travel agency based in Taipei, Taiwan, founded in 2013. The company specializes in package tour products, initially providing a marketplace for suppliers and a simple search engine for customers seeking suitable travel options. Over time, Tripresso expanded its offerings to include hotels, flight tickets, and customized travel plans for outbound travel. In 2018, it introduced TripSaaS, a proprietary software-as-a-service platform designed for brick-and-mortar travel agencies. This system facilitates the management of websites, product listings, orders, and customer relationships, ultimately enhancing operational efficiency. By leveraging data and partnerships with both online and offline travel information sources, Tripresso creates efficient travel planning networks that help users discover affordable travel packages.

EirGenix is a Taiwan-based contract development and manufacturing organization that specializes in biologics. It offers cell line development and cell bank manufacturing, process development, analytical sciences and quality control, and cGMP manufacturing, including antibody-drug conjugate production. The company operates two business units: contract development and manufacturing operation and product development operation, applying its team’s experience to biosimilars, biobetters, and new biologics. It runs two PIC/S GMP facilities for mammalian and microbial production to support clinical trial and commercial manufacturing. Founded in 2012 and headquartered in New Taipei City, EirGenix also develops and provides biopharmaceutical products such as CRM197 carrier protein and a COVID-19 antigen rapid test.